ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
향후 몇 년 동안 오가노이드 및 스페로이드 시장 규모는 비약적인 성장이 예상됩니다. 2029년에는 CAGR 24.3%로 34억 4,000만 달러로 성장할 것입니다. 예측 기간 동안의 성장은 지속적인 기술 발전, 맞춤형 의료의 확대, 암 연구에서의 응용 강화, 윤리적 및 규제적 발전, 유기체 및 구면체 기술 기반의 상업적 제품 및 서비스 성장, 유기체 및 구면체 기술 연구자 양성을 위한 교육 이니셔티브의 증가 등에 기인합니다. 예측 기간 동안 주요 동향으로는 첨단 기술과의 통합, 신약 개발을 위한 오가노이드를 이용한 고처리량 스크리닝 방법의 확대, 3D 바이오프린팅 및 바이오패브리케이션, 다양한 암 모델링에서 오가노이드의 사용 증가, 오가노이드와 미세유체 시스템과의 통합 등이 있습니다. 시스템과의 통합 등을 들 수 있습니다.
향후 5년간 24.3%의 성장률 예측은 지난번 예측보다 0.2% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 3D 바이오프린터(독일)와 세포외 매트릭스 하이드로겔(한국)의 비용을 상승시키고, 약물 스크리닝을 지연시키고, 전임상 개발 비용을 상승시킴으로써 미국의 생물의학 연구를 방해할 것으로 예상됩니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
세포 치료 및 조직공학에 대한 수요 증가는 향후 오가노이드 및 스페로이드 시장 확대를 견인할 것으로 예상됩니다. 세포 치료와 조직공학은 체내 손상된 조직이나 장기를 대체, 복구, 재생하기 위해 살아있는 세포나 인공조직을 이용하는 것입니다. 이러한 치료법은 손상된 조직을 재생하고 불치병으로 여겨졌던 질환을 치료할 수 있는 잠재력을 가지고 있기 때문에 재생의료 분야의 혁신적인 솔루션을 제공함으로써 그 수요가 증가하고 있습니다. 오가노이드 및 스페로이드는 세포 치료 및 조직 공학에서 복잡한 조직을 모델링하고 시험관 내에서 치료 접근법을 테스트하는 데 사용됩니다. 예를 들어, 2023년 2월 미국 기반 연구자들을 위한 온라인 리소스인 Cell &Gene은 2022년 승인된 340개의 생물학적 제제 중 약 8%에 해당하는 27개의 FDA 승인 세포-유전자 치료제(CGT)가 있으며, 이는 2021년 22개의 승인보다 증가했다고 보고했습니다. 보고하고 있습니다. 이러한 세포 치료 및 조직공학에 대한 수요 증가는 오가노이드 및 스페로이드 시장의 성장을 뒷받침할 것으로 예상됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 오가노이드 및 스페로이드 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 오가노이드 및 스페로이드 시장 : 성장률 분석
세계의 오가노이드 및 스페로이드 시장 실적 : 규모와 성장, 2019-2024
세계의 오가노이드 및 스페로이드 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 오가노이드 및 스페로이드 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 오가노이드 및 스페로이드 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
오가노이드
스페로이드
세계의 오가노이드 및 스페로이드 시장 : 방법별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세포외 기질 스캐폴드 법
회전식 바이오리액터 법
행잉 드롭 법
저접착성 배양 플레이트법
자기 부상 방식
기타 방법
세계의 오가노이드 및 스페로이드 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
발생생물학
맞춤형 의료
재생의료
질환 병리학 연구
약물 독성 및 유효성 시험
세계의 오가노이드 및 스페로이드 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
바이오테크놀러지와 제약 업계
학술연구기관
병원과 진단 센터
세계의 오가노이드 및 스페로이드 시장 : 하위 세분화 오가노이드(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
장관 오가노이드
간 오가노이드
뇌 오가노이드
신장 오가노이드
폐 오가노이드
췌장 오가노이드
심장 오가노이드
망막 오가노이드
종양 오가노이드
질환 모델을 위한 오가노이드
세계의 오가노이드 및 스페로이드 시장 : 하위 세분화 스페로이드(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
암스페로이드
신경 구형 몸
심장 스페로이드
간스페로이드
근육 구형 몸
내피스페로이드
줄기세포 유래 스페로이드
3D 세포배양 스페로이드
제7장 지역별·국가별 분석
세계의 오가노이드 및 스페로이드 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 오가노이드 및 스페로이드 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
오가노이드 및 스페로이드 시장 : 경쟁 구도
오가노이드 및 스페로이드 시장 : 기업 개요
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis
Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
StemCell Technologies Canada Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Greiner Bio-One International AG
Promega Corporation
Molecular Devices LLC
American Type Culture Collection(ATCC)
Mimetas B.V.
InSphero AG
HUB Organoids
Emulate Inc.
3D Biomatrix Inc.
Prellis Biologics Inc.
3D Biotek LLC
DefiniGEN Limited
Visikol Inc.
Organovo Holdings Inc.
Cellesce Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
오가노이드 및 스페로이드 시장 2029 : 새로운 기회를 제공하는 국가
오가노이드 및 스페로이드 시장 2029 : 새로운 기회를 제공하는 부문
오가노이드 및 스페로이드 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Organoids and spheroids are advanced 3D cell culture systems designed to replicate the structure and function of organs and tissues. Organoids are small, simplified versions of organs created from stem cells, while spheroids are spherical clusters of cells that can model tumor environments or various tissue types. These systems are utilized for research purposes such as disease modeling and drug testing.
The primary types of these models are organoids and spheroids. Organoids are miniature organ replicas grown in vitro from stem cells, used for investigating organ development, disease mechanisms, and drug effects. Techniques for generating organoids include the extracellular matrix scaffold method, spinning bioreactor method, hanging drop method, low adherent culture plate method, magnetic levitation method, and others. Applications of these models span developmental biology, personalized and regenerative medicine, disease pathology, drug toxicity studies, and efficacy testing. Key users include the biotechnology and pharmaceutical industries, academic and research institutions, and hospitals and diagnostic centers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The organoids and spheroids market research report is one of a series of new reports from The Business Research Company that provides organoids and spheroids market statistics, including the organoids and spheroids industry's global market size, regional shares, competitors with an organoids and spheroids market share, detailed organoids and spheroids market segments, market trends and opportunities, and any further data you may need to thrive in the organoids and spheroids industry. This organoids and spheroids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The organoids and spheroids market size has grown exponentially in recent years. It will grow from $1.16 billion in 2024 to $1.44 billion in 2025 at a compound annual growth rate (CAGR) of 24.3%. The growth in the historic period can be attributed to rapid progress in stem cell research and 3d cell culture technologies, increased funding and investments, rise in chronic diseases, increased use of organoids and spheroids in drug screening and toxicology studies, progress in regenerative medicine and personalized medicine approaches, favorable regulatory frameworks supporting the use of advanced cell culture models in research.
The organoids and spheroids market size is expected to see exponential growth in the next few years. It will grow to $3.44 billion in 2029 at a compound annual growth rate (CAGR) of 24.3%. The growth in the forecast period can be attributed to continued technological advancements, expansion of personalized medicine, enhanced applications in cancer research, ethical and regulatory evolution, growth in commercial products and services based on organoid and spheroid technologies, increased educational initiatives to train researchers in organoid and spheroid technologies. Major trends in the forecast period include integration with advanced technologies, expansion of high-throughput screening methods using organoids for drug discovery, 3D bioprinting and bio fabrication, increasing use of organoids for modeling various cancers, and integration of organoids with microfluidic systems.
The forecast of 24.3% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. biomedical research by increasing the cost of 3D bioprinters (Germany) and extracellular matrix hydrogels (South Korea), thereby delaying drug screening and elevating preclinical development costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growing demand for cell therapy and tissue engineering is expected to drive the expansion of the organoids and spheroids market in the future. Cell therapy and tissue engineering involve utilizing living cells or engineered tissues to replace, repair, or regenerate damaged tissues and organs in the body. This demand is increasing due to the potential of these therapies to regenerate damaged tissues and treat conditions previously considered incurable, thus providing innovative solutions in regenerative medicine. Organoids and spheroids are used in cell therapy and tissue engineering to model complex tissues and test therapeutic approaches in vitro. For example, in February 2023, Cell & Gene, a U.S.-based online resource for research scholars, reported that there were 27 FDA-approved cell and gene therapies (CGTs), representing about 8% of the 340 biologics approved in 2022, an increase from 22 approvals in 2021. This growing demand for cell therapy and tissue engineering is anticipated to support the growth of the organoids and spheroids market.
Leading companies in the organoids and spheroids market are concentrating on developing advanced tools, such as single-particle dispensers, to enhance precision in cell handling and improve the reproducibility of research outcomes. Single-particle dispensers are high-precision instruments designed to isolate and dispense individual cells or particles, enabling accurate control in research and diagnostic applications. For example, in July 2024, SEED Biosciences, a biotechnology company based in Switzerland, launched Dispen3D, an innovative tool for accurately dispensing individual spheroids and organoids, representing a significant advancement in 3D cellular model handling. This dispenser allows researchers to transfer single spheroids into multi-well plates swiftly and precisely, automating the process and ensuring monoclonality, which is essential for drug discovery and personalized medicine. Dispen3D operates at low pressures, delicately treating fragile cells to maintain their structural integrity and viability, while its user-friendly design allows for seamless integration into diverse research settings, meeting the increasing demand for advanced instruments in biological sciences.
In February 2024, Cell Microsystems, a U.S.-based biotechnology company, formed a strategic partnership with OMNI Life Science to significantly advance life science research in North America through the introduction of advanced cell analysis tools. This collaboration focuses on launching three innovative products: the TIGR Tissue Grinder & Dissociator, the CASY Cell Counter and Analyzer, and the CERO 3D Cell Culture Incubator & Bioreactor. OMNI Life Science, a Germany-based company, specializes in laboratory instrumentation and solutions for life sciences research.
Major companies operating in the organoids and spheroids market are Thermo Fisher Scientific Inc., Merck KGaA, Corning Incorporated, Lonza Group AG, StemCell Technologies Canada Inc., Greiner Bio-One International AG, Promega Corporation, Molecular Devices LLC, American Type Culture Collection (ATCC), Mimetas B.V., InSphero AG, HUB Organoids, Emulate Inc., 3D Biomatrix Inc., Prellis Biologics Inc., 3D Biotek LLC, DefiniGEN Limited, Visikol Inc., Organovo Holdings Inc., Cellesce Ltd., AMS Biotechnology (Europe) Limited
North America was the largest region in the organoids and spheroids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the organoids and spheroids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the organoids and spheroids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The organoids and spheroids market includes revenues earned by entities by providing services such as drug discovery and testing, toxicology screening, personalized medicine, regenerative medicine research, cancer research, stem cell research, and gene editing studies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Organoids And Spheroids Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on organoids and spheroids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for organoids and spheroids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The organoids and spheroids market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Organoids; Spheroids
2) By Method: Extracellular Matrix Scaffold Method; Spinning Bioreactor Method; Hanging Drop Method; Low Adherent Culture Plate Method; Magnetic levitation Method; Other Methods
3) By Application: Developmental Biology; Personalized Medicine; Regenerative Medicine; Disease Pathology Studies; Drug Toxicity And Efficacy Testing
4) By End User: Biotechnology And Pharmaceutical Industry; Academic And Research Institutes; Hospitals And Diagnostic Centers
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Organoids And Spheroids Market Characteristics
3. Organoids And Spheroids Market Trends And Strategies
4. Organoids And Spheroids Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Organoids And Spheroids Growth Analysis And Strategic Analysis Framework
5.1. Global Organoids And Spheroids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Organoids And Spheroids Market Growth Rate Analysis
5.4. Global Organoids And Spheroids Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Organoids And Spheroids Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Organoids And Spheroids Total Addressable Market (TAM)
6. Organoids And Spheroids Market Segmentation
6.1. Global Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Organoids
Spheroids
6.2. Global Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Extracellular Matrix Scaffold Method
Spinning Bioreactor Method
Hanging Drop Method
Low Adherent Culture Plate Method
Magnetic Levitation Method
Other Methods
6.3. Global Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Developmental Biology
Personalized Medicine
Regenerative Medicine
Disease Pathology Studies
Drug Toxicity And Efficacy Testing
6.4. Global Organoids And Spheroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biotechnology And Pharmaceutical Industry
Academic And Research Institutes
Hospitals And Diagnostic Centers
6.5. Global Organoids And Spheroids Market, Sub-Segmentation Of Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intestinal Organoids
Liver Organoids
Brain Organoids
Kidney Organoids
Lung Organoids
Pancreatic Organoids
Cardiac Organoids
Retinal Organoids
Tumor Organoids
Organoids For Disease Modeling
6.6. Global Organoids And Spheroids Market, Sub-Segmentation Of Spheroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer Spheroids
Neural Spheroids
Cardiac Spheroids
Liver Spheroids
Muscle Spheroids
Endothelial Spheroids
Stem Cell-Derived Spheroids
3D Cell Culture Spheroids
7. Organoids And Spheroids Market Regional And Country Analysis
7.1. Global Organoids And Spheroids Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Organoids And Spheroids Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Organoids And Spheroids Market
8.1. Asia-Pacific Organoids And Spheroids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Organoids And Spheroids Market
9.1. China Organoids And Spheroids Market Overview
9.2. China Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Organoids And Spheroids Market
10.1. India Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Organoids And Spheroids Market
11.1. Japan Organoids And Spheroids Market Overview
11.2. Japan Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Organoids And Spheroids Market
12.1. Australia Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Organoids And Spheroids Market
13.1. Indonesia Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Organoids And Spheroids Market
14.1. South Korea Organoids And Spheroids Market Overview
14.2. South Korea Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Organoids And Spheroids Market
15.1. Western Europe Organoids And Spheroids Market Overview
15.2. Western Europe Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Organoids And Spheroids Market
16.1. UK Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Organoids And Spheroids Market
17.1. Germany Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Organoids And Spheroids Market
18.1. France Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Organoids And Spheroids Market
19.1. Italy Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Organoids And Spheroids Market
20.1. Spain Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Organoids And Spheroids Market
21.1. Eastern Europe Organoids And Spheroids Market Overview
21.2. Eastern Europe Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Organoids And Spheroids Market
22.1. Russia Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Organoids And Spheroids Market
23.1. North America Organoids And Spheroids Market Overview
23.2. North America Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Organoids And Spheroids Market
24.1. USA Organoids And Spheroids Market Overview
24.2. USA Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Organoids And Spheroids Market
25.1. Canada Organoids And Spheroids Market Overview
25.2. Canada Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Organoids And Spheroids Market
26.1. South America Organoids And Spheroids Market Overview
26.2. South America Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Organoids And Spheroids Market
27.1. Brazil Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Organoids And Spheroids Market
28.1. Middle East Organoids And Spheroids Market Overview
28.2. Middle East Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Organoids And Spheroids Market
29.1. Africa Organoids And Spheroids Market Overview
29.2. Africa Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Organoids And Spheroids Market Competitive Landscape And Company Profiles
30.1. Organoids And Spheroids Market Competitive Landscape
30.2. Organoids And Spheroids Market Company Profiles
30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. StemCell Technologies Canada Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Organoids And Spheroids Market Other Major And Innovative Companies
31.1. Greiner Bio-One International AG
31.2. Promega Corporation
31.3. Molecular Devices LLC
31.4. American Type Culture Collection (ATCC)
31.5. Mimetas B.V.
31.6. InSphero AG
31.7. HUB Organoids
31.8. Emulate Inc.
31.9. 3D Biomatrix Inc.
31.10. Prellis Biologics Inc.
31.11. 3D Biotek LLC
31.12. DefiniGEN Limited
31.13. Visikol Inc.
31.14. Organovo Holdings Inc.
31.15. Cellesce Ltd.
32. Global Organoids And Spheroids Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Organoids And Spheroids Market
34. Recent Developments In The Organoids And Spheroids Market
35. Organoids And Spheroids Market High Potential Countries, Segments and Strategies
35.1 Organoids And Spheroids Market In 2029 - Countries Offering Most New Opportunities
35.2 Organoids And Spheroids Market In 2029 - Segments Offering Most New Opportunities
35.3 Organoids And Spheroids Market In 2029 - Growth Strategies
